England’s NHS to improve cancer treatment using Elekta’s ProKnow solution
CRAWLEY, UK – Elekta (EKTA-B.ST) announced today that the National Health Service Supply Chain (NHSSC) has ordered multiple licenses for Elekta’s ProKnow® software solution, which centralizes and analyzes radiotherapy data in a secure scalable platform, accessible to the NHS England’s (NHSE’s) radiation oncology facilities throughout the country.
The order was made after a rigorous evaluation, where the NHS required a solution to gather big data and drive improvements and standardization across England. ProKnow was chosen for its ease of use in enabling health care providers to benchmark their treatment planning metrics against UK best practice and support ongoing consistency and clinical excellence. The order includes ProKnow licenses for 50 NHS Trust hospitals over three years as well as education and training.
Maurits Wolleswinkel, Elekta’s Chief Product Officer, says: “By offering ProKnow to its workforce, the NHS is enabling unique capabilities for data management, evaluation of patient treatment strategies, and plan review tasks across its network of hospitals and clinics. Furthermore, it demonstrates the strength of ProKnow’s cloud-based, vendor-neutral platform as it can be used with internet access through a browser by radiation therapy departments anywhere, regardless of their linac manufacturer, treatment planning system or oncology information solution.”
ProKnow allows collective data from cancer groups to be analyzed, offering oncology teams big data insights. The solution can also streamline workflow challenges and improve contouring accuracy and treatment plan quality. The technology is vendor agnostic and is used today by healthcare networks with a variety of treatment planning systems.
For more information about ProKnow, visit https://proknow.com/
# # #
For further information, please contact:
Mattias Thorsson, Vice President, Head of Corporate Communications
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time
Raven Canzeri, Global Director, Media Relations
Tel: +1 770-670-2524, e-mail: Raven.Canzeri@elekta.com
Time zone: ET: Eastern Time
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope.
Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.